Tuberous sclerosis, a disease in which mTORC1 is over-activated by TSC1 or TSC2 deletion, which leads to the formation of a wide range of benign tumors, is also direct evidence that mTORC1 plays a key role in tumorigenesis. This evidence concerns the gene TSC2 and benign neoplasm.